Onconova Therapeutics, Inc.·4

Nov 27, 8:33 AM ET

MEHTA VIREN 4

4 · Onconova Therapeutics, Inc. · Filed Nov 27, 2019

Insider Transaction Report

Form 4
Period: 2019-11-25
MEHTA VIREN
Director
Transactions
  • Purchase

    Common Stock

    2019-11-25$0.20/sh+250,000$50,000250,857 total
  • Purchase

    Warrant (right to purchase)

    2019-11-25+250,000250,000 total
    Exercise: $0.20From: 2019-11-25Exp: 2024-11-25Common Stock (250,000 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    54
  • Common Stock

    (indirect: By Foundation)
    56
Footnotes (4)
  • [F1]The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20.
  • [F2]Includes 190 shares held jointly with Dr. Mehta's spouse.
  • [F3]Dr. Mehta, as managing member, has voting and dispositive power with regard to the shares held by Mehta Partners, LLC.
  • [F4]Dr. Mehta, as trustee, has voting and dispositive power with regard to the shares held by Viram Foundation.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -